✦ LIBER ✦

P.2.c.021 Levomilnacipran in the treatment of major depressive disorder: an analysis of efficacy and safety data from two phase III studies

✍ Scribed by W. Greenberg; C. Gommoll; A. Bose; H. Li; A. Ruth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.c.020 The efficacy and safety of lev

✍ A. Bose; C. Chen; C. Gommoll; A. Ruth; J. Terner-Rosenthal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 71 KB

P.2.c.022 Levomilnacipran in the treatme

✍ S. Blum; S. Tourkodimitris; A. Ruth; J. Terner-Rosenthal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB

PMH52 Levomilnacipran in the Treatment o

✍ S.I. Blum; S. Tourkodimitris; A. Ruth 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

P.2.c.006 Efficacy and clinical relevanc

✍ A. Khan; W. Song; J. Edwards; A. Ruth 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

P.2.c.031 Safety and tolerability of adj

✍ J.Y. Loze; R. Gismondi; R. McQuade; W. Carson; R. Berman 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Efficacy of bupropion and the selective

✍ George I. Papakostas; Madhukar H. Trivedi; Jonathan E. Alpert; Cheryl A. Seifert 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 176 KB